Home
Program Partners
Oncode Accelerator has six coordinating partners: Leiden University, Leiden University Medical Center, the Netherlands Cancer Institute, Princess Máxima Center, UMC Utrecht and the Oncode Accelerator Foundation, who each lead individual consortia within the Oncode Accelerator program.
The individual consortia, led by the program coordinating partners are referred to as Workstreams and Platforms. Together, the ten individual consortia make up the overall Oncode Accelerator program.
- Leiden University is in the lead for the Small Molecules Workstream and Artificial Intelligence Platform;
- Leiden University Medical Center leads the Therapeutic Vaccines Workstream
- Netherlands Cancer Institute is the lead party for the Cell and Gene Therapy Workstream;
- University Medical Center Utrecht leads the Biologics Workstream and well-defined Patient Cohorts Platform;
- Princess Máxima Center for pediatric oncology leads the Organoids Platform;
- The Oncode Accelerator Foundation is in the lead for three overarching central Workstreams: Regulatory innovation, Demonstrator Projects and Program (Central) Coordination.
Our mission is bold, we aim to collaboratively optimize and accelerate the development of
new cancer therapies for the benefit of patients of all ages. Oncode Accelerator is a dynamic collaboration of more than 35 public and private partners from different corners of the oncology ecosystem:
